Overview
- First invitations have gone out and initial testing has begun at the InHealth community diagnostic centre in Ealing.
- Stage one will recruit 16,000 men aged 50–74, or 45–74 for higher‑risk groups, with participants invited directly by their GPs rather than volunteering.
- The study will benchmark PSA blood tests, genetic risk testing and rapid MRI scans against current NHS diagnostic pathways.
- Funding totals £42 million, with £16 million from the NIHR and the remainder from Prostate Cancer UK and its partners, and the trial will build a large bank of samples, images and data for future research.
- Approaches that perform best will be tested in up to 300,000 men in a subsequent phase, with at least one in ten invitations to Black men, as the National Screening Committee considers a prostate screening recommendation that reporting suggests may focus on high‑risk groups.